LA
TEVA icon

LM Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

LM Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,500
Closed -$15.7K – 658
2023
Q4 		$15.7K Buy
+1,500
New +$14K ﹤0.01% 472

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LM Advisors's TEVA Position: Q1 2024 in Review

LM Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2024, closing a stake of 1,500 shares — an estimated $15.7K sold.

LM Advisors first reported a position in TEVA in Q4 2023 and held it in 1 quarter. The position peaked at $15.7K in Q4 2023. 481 funds tracked by Wall St. Rank hold TEVA as of Q1 2024.

  • LM Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • LM Advisors sold 1,500 Teva Pharmaceuticals shares in Q1 2024, an estimated $15.7K.
  • LM Advisors first reported a position in Teva Pharmaceuticals in Q4 2023 and held it in 1 quarter.
  • LM Advisors's Teva Pharmaceuticals position peaked at $15.7K in Q4 2023.
  • 481 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2024.

Based on LM Advisors's 13F filing for Q1 2024, filed 15 May 2024.